Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Higher levels of certain proteins in hair loss areas may help understand and treat hair loss.

Rodent models helped understand psoriasis but none perfectly replicated the disease.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Somatostatin may help protect hair follicles from immune attacks.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Finasteride can cause a unique skin reaction on the penile shaft.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A new mouse model for vitiligo helps study immune responses and potential treatments.

ILC1 cells contribute to hair loss in alopecia areata.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Targeting specific T cells may help treat alopecia areata.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.